查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726339

全球基于 NGS 的 RNA 定序市场：市场规模、份额、趋势分析（按产品/服务、工作流程、应用、最终用途和地区）、细分市场预测（2025-2030 年）

NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

基于NGS的RNA定序市场成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球基于 NGS 的 RNA 定序市场规模预计到 2030 年将达到 100.5 亿美元，2025 年至 2030 年的复合年增长率为 17.3%。

这种增长是由精准医疗需求的不断增长、测序技术的进步以及诊断、药物发现和疾病研究领域应用的不断扩大所推动的。生物资讯能力的不断扩大和测序成本的下降进一步推动了市场应用。

COVID-19 大流行加速了基于 NGS 的 RNA 测序的采用，因为它在了解病毒突变、宿主反应和病原体转录组学方面发挥关键作用。疫苗和治疗开发中迫切需要先进的基因组工具，凸显了 RNA 定序的价值，并促使其迅速融入研究和公共卫生工作。这种转变进一步增强了RNA定序在感染疾病监测和预防中的重要性。

此外，高通量定序技术的进步显着提高了 RNA 定序的速度、准确性和可扩展性。这些创新使得转录组分析更加全面、週转时间更快、成本更低，并且使基于 NGS 的 RNA 定序更适用于研究和临床应用。

然而，定序平台和基础设施的高初始成本，以及对使用基因组数据的道德担忧，预计会阻碍市场成长。这些挑战可能会限制采用，特别是在资源受限的环境和资料隐私法规严格的地区。

基于NGS的RNA定序市场报告重点

  • 按产品和服务划分，由于试剂化学的不断进步以及对高品质、高效测序试剂套件的需求不断增加，预计耗材部门将在 2024 年占据最大的收益占有率，达到 58.12%。然而，预计在预测期内服务业将以最快的复合年增长率成长。
  • 根据工作流程，由于越来越多地采用提供快速週转和具有成本效益的处理的先进平台，预计定序部分将在 2024 年占据最大的市场占有率。另一方面，数据分析部分预计在预测期内实现 18.49% 的复合年增长率。
  • 根据应用，药物发现和开发将在 2024 年占据应用领域最大的收益占有率。这是由于 RNA 定序在识别新标靶和加速治疗方法开发方面的应用日益增加。然而，临床诊断领域预计在预测期内的复合年增长率最高。
  • 根据最终用途，製药和生物技术公司在 2024 年占据最大份额。这种增长是由 RNA 测序在生物标记发现、临床研究和个人化药物开发中的日益普及所推动的。另一方面，医院和诊所部门预计在预测期内将实现最快的成长率。
  • 由于先进的医疗基础设施、强大的研究资金以及精准医疗和基因组技术的高度采用等因素，北美在基于 NGS 的 RNA 测序市场中占据主导地位。预计在预测期内亚太地区将以最快的复合年增长率成长。

目录

第一章 分析方法与范围

第二章执行摘要

3. 基于NGS的RNA定序市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 基于NGS的RNA定序市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章基于NGS的RNA定序市场：按产品和服务的估计和趋势分析

  • 产品/服务仪表板
  • 全球基于NGS的RNA定序市场（依变异分析、产品和服务）
  • 全球基于 NGS 的 RNA 定序市场：按产品和服务分類的市场规模和趋势分析（2018-2030 年）
  • 耗材
    • 萃取精製套件
    • 样品製备套件
    • 定序试剂和流动槽
    • 其他的
  • 装置
  • 服务
    • RNA定序
    • 生物资讯数据分析

5. 以NGS为基础的RNA定序市场：依工作流程的估算与趋势分析

  • 工作流程仪表板
  • 全球基于NGS的RNA定序市场（按变异分析和工作流程）
  • 全球基于 NGS 的 RNA 定序市场：按工作流程分類的市场规模和趋势分析（2018-2030 年）
  • 前序列
  • 定序
  • 数据分析

6. 基于NGS的RNA定序市场：按应用的估值和趋势分析

  • 特定于应用程式的仪表板
  • 全球基于NGS的RNA定序市场（依变异分析与应用）
  • 全球基于 NGS 的 RNA 定序市场：按应用分類的市场规模和趋势分析（2018-2030 年）
  • 应用程式细分仪表板
  • 全球基于NGS的RNA定序市场应用差异分析
  • 2018-2030年全球基于NGS的RNA定序市场规模及应用趋势分析
  • 药物研发
    • 瘤
    • 感染疾病
    • 其他的
  • 临床诊断
  • 其他的

7. 以NGS为基础的RNA定序市场：依最终用途的估算与趋势分析

  • 最终用途仪表板
  • 全球基于NGS的RNA定序市场（按变异分析和最终用途）
  • 全球基于 NGS 的 RNA 定序市场：按最终用途分類的市场规模和趋势分析（2018-2030 年）
  • 製药和生物技术公司
  • 医院和诊所
  • 学术研究所
  • 其他的

第 8 章基于 NGS 的 RNA定序市场：区域估计和趋势分析（按产品/服务、工作流程、应用和最终用途）

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 企业市场分析（2024年）
  • 公司简介/上市公司
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Merck KGaA
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Ltd.
    • BGI Group
    • Agilent Technologies, Inc.
    • Roche Holding AG
    • Revvity, Inc.
Product Code: GVR-4-68040-560-4

NGS-based RNA-sequencing Market Growth & Trends:

The global NGS-based RNA-sequencing market size is expected to reach USD 10.05 billion by 2030 and is anticipated to grow at a CAGR of 17.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to rising demand for precision medicine, advancements in sequencing technologies, and increasing applications in diagnostics, drug discovery, and disease research. Expanding bioinformatics capabilities and declining sequencing costs further support widespread market adoption.

The COVID-19 pandemic has accelerated the adoption of NGS-based RNA-sequencing owing to its critical role in understanding viral mutations, host response, and pathogen transcriptomics. The urgent need for advanced genomic tools in vaccine and therapeutic development highlighted the value of RNA-sequencing, driving rapid integration into research and public health efforts. This shift has reinforced its importance in infectious disease monitoring and preparedness.

In addition, advancements in high-throughput sequencing technologies have significantly enhanced the speed, accuracy, and scalability of RNA-sequencing. These innovations enable more comprehensive transcriptome profiling, reduce turnaround times, and lower costs, making NGS-based RNA sequencing more accessible for both research and clinical applications.

However, high initial costs associated with sequencing platforms and infrastructure, and ethical concerns surrounding genomic data usage are expected to hamper market growth. These challenges may limit adoption, particularly in resource-constrained settings and regions with stringent data privacy regulations.

NGS-based RNA-sequencing Market Report Highlights:

  • Based on product and service, the consumables segment dominated with the largest revenue share of 58.12% in 2024, due to continuous advancements in reagent chemistry and the growing demand for quality, efficient sequencing kits. However, services are expected to grow at the fastest CAGR over the forecast period.
  • Based on workflow, the sequencing segment held the largest market share in 2024, driven by increased adoption of advanced platforms offering faster turnaround and cost-effective processing. On the other hand, the data analysis segment is anticipated to witness the fastest CAGR of 18.49% over the forecast period.
  • Based on application, the drug discovery & development segment holds the largest revenue share for application in 2024. This is attributed to the growing use of RNA-sequencing in identifying novel targets and accelerating therapeutic development. However, the clinical diagnostics segment is projected to grow at the highest CAGR over the forecast period.
  • Based on end use, the pharmaceutical & biotechnology companies segment held the largest share in 2024. The growth is due to increased adoption of RNA-sequencing for biomarker discovery, clinical research, and personalized drug development. On the other hand, the hospitals & clinics segment is expected to register the fastest growth rate during the projected period.
  • North America dominated the NGS-based RNA-sequencing market owing to factors such as advanced healthcare infrastructure, strong research funding, and high adoption of precision medicine and genomic technologies. Asia Pacific is expected to grow at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Workflow
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. NGS-based RNA-sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for precision and personalized medicine
      • 3.2.1.2. Growing applications in biomarker discovery and drug development
      • 3.2.1.3. Integration of AI and bioinformatics for data interpretation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High initial costs associated with sequencing platforms and infrastructure
      • 3.2.2.2. Ethical issues surrounding genomic data usage
  • 3.3. NGS-based RNA-sequencing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. NGS-based RNA-sequencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global NGS-based RNA-sequencing Market Product & Service Movement Analysis
  • 4.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Extraction & Purification Kits
      • 4.4.2.1. Extraction & purification kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Library Preparation Kits
      • 4.4.3.1. Library preparation kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Sequencing Reagents & Flow Cells
      • 4.4.4.1. Sequencing reagents & flow cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. RNA-sequencing
      • 4.6.2.1. RNA-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Bioinformatics & Data Analysis
      • 4.6.3.1. Bioinformatics & data analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. NGS-based RNA-sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. Global NGS-based RNA-sequencing Market Workflow Movement Analysis
  • 5.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Pre-sequencing
    • 5.4.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Sequencing
    • 5.5.1. Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Data Analysis
    • 5.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. NGS-based RNA-sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global NGS-based RNA-sequencing Market Application Movement Analysis
  • 6.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug discovery & development market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Oncology
      • 6.4.2.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Infectious Diseases
      • 6.4.3.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Diagnostics
    • 6.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. NGS-based RNA-sequencing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global NGS-based RNA-sequencing Market End Use Movement Analysis
  • 7.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. NGS-based RNA-sequencing Market: Regional Estimates & Trend Analysis by Product & Service, Workflow, Application, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Illumina, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Thermo Fisher Scientific Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. QIAGEN N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Pacific Biosciences of California, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Oxford Nanopore Technologies Ltd.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. BGI Group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Agilent Technologies, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Roche Holding AG
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Revvity, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global NGS-based RNA-sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 U.S. NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Canada NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Mexico NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Mexico NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Europe NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 Germany NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Germany NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 UK NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 36 UK NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 France NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 France NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 France NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Italy NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Italy NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Spain NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Denmark NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Denmark NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 54 Sweden NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 55 Sweden NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 56 Sweden NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 57 Norway NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Norway NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 59 Norway NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 60 Norway NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 61 Asia Pacific NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 64 Asia Pacific NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 65 Asia Pacific NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 66 China NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 China NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 China NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 China NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Japan NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Japan NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 India NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 India NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 77 India NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 79 South Korea NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 South Korea NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Australia NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Australia NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Thailand NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 Thailand NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Latin America NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Latin America NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 Brazil NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Brazil NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 100 Argentina NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 MEA NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 South Africa NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 UAE NGS-based RNA-sequencing market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 118 UAE NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 NGS-based RNA-sequencing market: Market outlook
  • Fig. 5 NGS-based RNA-sequencing market: Segment outlook
  • Fig. 6 NGS-based RNA-sequencing market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 NGS-based RNA-sequencing market driver impact
  • Fig. 9 NGS-based RNA-sequencing market restraint impact
  • Fig. 10 NGS-based RNA-sequencing market: Product & services outlook and key takeaways
  • Fig. 11 NGS-based RNA-sequencing market: Product & services movement analysis
  • Fig. 12 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Extraction & purification kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Labeling reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Sequencing reagents & flow cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bioinformatics & data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 NGS-based RNA-sequencing market: Workflow outlook and key takeaways
  • Fig. 23 NGS-based RNA-sequencing market: Workflow movement analysis
  • Fig. 24 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 NGS-based RNA-sequencing market: Application outlook and key takeaways
  • Fig. 28 NGS-based RNA-sequencing market: Application movement analysis
  • Fig. 29 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 NGS-based RNA-sequencing market: End use outlook and key takeaways
  • Fig. 36 NGS-based RNA-sequencing market: End use movement analysis
  • Fig. 37 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals & clinical market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global NGS-based RNA-sequencing market: Regional outlook and key takeaways
  • Fig. 42 Global NGS-based RNA-sequencing market: Regional movement analysis
  • Fig. 43 North America NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)